Understanding glycan-sensitive vs glycan-agnostic PD-1 antibodies using 3decision 2.0
This article by Marija Martini summarizes important studies on the programmed cell death-1 receptor (PD-1) glycosylation and its influence on immunotherapeutics discovery, using new features from the 3decision V2.0 release.